Lista de obras - Holly Fernandez Lynch - Dominio Público Uruguay

A Framework for Ethical Payment to Research Participants

scholarly article

A Functional Approach to Assessing Consent for Biospecimen Research

artículo científico publicado en 2017

A Proposal to Address NFL Club Doctors' Conflicts of Interest and to Promote Player Trust

artículo científico publicado en 2016

A Response to Commentaries

artículo científico publicado en 2016

Academic Advocacy: Opportunities to Influence Health and Science Policy Under U.S. Lobbying Law

scientific article published on 08 October 2019

Adding insult to injury: reluctance to engage in clinical research with at-risk groups further disenfranchises these populations

artículo científico publicado en 2009

Addressing Financial Barriers to Enrollment in Clinical Trials

artículo científico publicado en 2018

Association Between Financial Incentives and Participant Deception About Study Eligibility

article published in 2019

Biospecimens, Research Consent, and Distinguishing Cell Line Research

artículo científico publicado en 2019

Compensating for research risk: permissible but not obligatory

scientific article published on 13 October 2020

Compliance with advance directives. Wrongful living and tort law incentives.

artículo científico publicado en 2008

Confronting Biospecimen Exceptionalism in Proposed Revisions to the Common Rule

artículo científico publicado en 2016

Contraceptive Coverage and the Balance Between Conscience and Access

artículo científico publicado en 2017

Designing development programs for non-traditional antibacterial agents

artículo científico publicado en 2019

Differential payment to research participants in the same study: an ethical analysis

artículo científico publicado en 2019

Discrimination at the doctor's office

artículo científico publicado en 2013

Emergency Approvals for COVID-19: Evolving Impact on Obligations to Patients in Clinical Care and Research

artículo científico publicado en 2020

Ethical Review and Methodologic Innovation in Phase 1 Cancer Trials-Reply

artículo científico publicado en 2019

Ethical evasion or happenstance and hubris? The U.S. Public Health Service STD Inoculation Study

artículo científico publicado en 2012

Ethics of controlled human infection to study COVID-19

scientific article published on 07 May 2020

Evaluating the Quality of Research Ethics Review and Oversight: A Systematic Analysis of Quality Assessment Instruments

scientific article published on 21 August 2020

Facilitating Both Evidence and Access: Improving FDA's Accelerated Approval and Expanded Access Pathways

artículo científico publicado en 2020

Federal Right-to-Try Legislation - Threatening the FDA's Public Health Mission

artículo científico publicado en 2018

Filthy Lucre or Fitting Offer? Understanding Worries About Payments to Research Participants

scientific article published on 01 September 2019

Give them what they want? The permissibility of pediatric placebo-controlled trials under the best pharmaceuticals for children act

artículo científico publicado en 2007

Human research subjects as human research workers

article published in 2014

IRB Oversight of Patient-Centered Outcomes Research: A National Survey of IRB Chairpersons

artículo científico publicado en 2018

Implementing Regulatory Broad Consent Under the Revised Common Rule: Clarifying Key Points and the Need for Evidence

artículo científico publicado en 2019

Incorporating ethical principles into clinical research protocols: a tool for protocol writers and ethics committees

artículo científico publicado en 2016

Informed Consent and the Role of the Treating Physician

article

Institutional Review Board Quality, Private Equity, and Promoting Ethical Human Subjects Research

artículo científico publicado en 2020

Institutions as an ethical locus of research prioritisation

Making the case for completion bonuses in clinical trials

artículo científico publicado en 2018

Minimal or reasonable? Considering the ethical threshold for research risks to nonconsenting bystanders and implications for nonconsenting participants

artículo científico publicado en 2020

Mountains and Molehills When Using Social Media as a Research Support Tool

artículo científico publicado en 2019

No Easy Answers in Allocating Unapproved COVID-19 Drugs Outside Clinical Trials

artículo científico publicado en 2020

Nonexceptionalism, Research Risks, and Social Media: Response to Open Peer Commentaries on "Using Social Media as a Research Recruitment Tool: Ethical Issues and Recommendations".

artículo científico publicado en 2017

Of Parachutes and Participant Protection: Moving Beyond Quality to Advance Effective Research Ethics Oversight

scientific article published on 12 December 2018

Offering Payment in Clinical Research: Enrolling Individuals With or at Risk for Opioid Use Disorder

artículo científico publicado en 2020

On Scarcity and the Value of Clinical Trials.

artículo científico publicado en 2018

Oversight of Patient-Centered Outcomes Research: Recommendations From a Delphi Panel

artículo científico publicado en 2018

Participant Protection in Phase 1 Pediatric Cancer Trials

scientific article published on 01 January 2019

Patient-Centered Outcomes Research: Stakeholder Perspectives and Ethical and Regulatory Oversight Issues

artículo científico publicado en 2018

Patient-Engaged Research: Choosing the "Right" Patients to Avoid Pitfalls

artículo científico publicado en 2018

Pay-to-Participate Trials and Vulnerabilities in Research Ethics Oversight

artículo científico publicado en 2019

Paying Clinical Trial Participants: Legal Risks and Mitigation Strategies

scientific article published on 14 June 2019

Paying Participants in COVID-19 Trials

artículo científico publicado en 2020

Paying Research Participants: Regulatory Uncertainty, Conceptual Confusion, and a Path Forward

artículo científico publicado en 2017

Paying Research Participants: The Outsized Influence of "Undue Influence".

artículo científico publicado en 2017

Prescription Requirements and Patient Autonomy: Considering an Over-the-Counter Default

artículo científico publicado en 2020

Promoting Patient Interests in Implementing the Federal Right to Try Act

artículo científico publicado en 2018

Protecting clinical trial participants and study integrity in the age of social media

artículo científico publicado en 2018

Public Engagement, Notice-and-Comment Rulemaking, and the Common Rule

artículo científico publicado en 2017

Reaping the Bounty of Publicly Available Clinical Trial Consent Forms

Regulating Research with Biospecimens under the Revised Common Rule

artículo científico publicado en 2017

Regulatory flexibility for COVID-19 research

scientific article published on 01 January 2020

Revised 'Common Rule' Shapes Protections For Research Participants.

artículo científico publicado en 2017

Right to Try Requests and Oncologists' Gatekeeping Obligations

scientific article published on 15 October 2019

Streamlining review by accepting equivalence

artículo científico publicado en 2014

The Journey Toward Routinization: Triage Nursing and the Success of an Emergency Department-Based Routine HIV Testing Program

artículo científico

The Legality of Biometric Screening of Professional Athletes

journal article; published in The American Journal of Bioethics in 2017

The right to withdraw from controlled human infection studies: Justifications and avoidance

scientific article published on 24 January 2020

The rights and wrongs of intentional exposure research: contextualising the Guatemala STD inoculation study

artículo científico

The role of community engagement in addressing bystander risks in research: The case of a Zika virus controlled human infection study

artículo científico publicado en 2020

Truth in Advertising: Disclosure of Participant Payment in Research Recruitment Materials

scientific article published on 08 April 2018

Unnecessary hesitancy on human vaccine tests-Response

artículo científico publicado en 2020

Using Social Media as a Research Recruitment Tool: Ethical Issues and Recommendations

artículo científico publicado en 2017

Waivers and Alterations of Research Informed Consent During the COVID-19 Pandemic

artículo científico publicado en 2020

When clinical trials compete: prioritising study recruitment

artículo científico publicado en 2017

When religious freedom clashes with access to care

artículo científico publicado en 2014

Lista de obras de Holly Fernandez Lynch

A Framework for Ethical Payment to Research Participants

A Functional Approach to Assessing Consent for Biospecimen Research

A Proposal to Address NFL Club Doctors' Conflicts of Interest and to Promote Player Trust

A Response to Commentaries

Academic Advocacy: Opportunities to Influence Health and Science Policy Under U.S. Lobbying Law

Adding insult to injury: reluctance to engage in clinical research with at-risk groups further disenfranchises these populations

Addressing Financial Barriers to Enrollment in Clinical Trials

Association Between Financial Incentives and Participant Deception About Study Eligibility

Biospecimens, Research Consent, and Distinguishing Cell Line Research

Compensating for research risk: permissible but not obligatory

Compliance with advance directives. Wrongful living and tort law incentives.

Confronting Biospecimen Exceptionalism in Proposed Revisions to the Common Rule

Contraceptive Coverage and the Balance Between Conscience and Access

Designing development programs for non-traditional antibacterial agents

Differential payment to research participants in the same study: an ethical analysis

Discrimination at the doctor's office

Emergency Approvals for COVID-19: Evolving Impact on Obligations to Patients in Clinical Care and Research

Ethical Review and Methodologic Innovation in Phase 1 Cancer Trials-Reply

Ethical evasion or happenstance and hubris? The U.S. Public Health Service STD Inoculation Study

Ethics of controlled human infection to study COVID-19

Evaluating the Quality of Research Ethics Review and Oversight: A Systematic Analysis of Quality Assessment Instruments

Facilitating Both Evidence and Access: Improving FDA's Accelerated Approval and Expanded Access Pathways

Federal Right-to-Try Legislation - Threatening the FDA's Public Health Mission

Filthy Lucre or Fitting Offer? Understanding Worries About Payments to Research Participants

Give them what they want? The permissibility of pediatric placebo-controlled trials under the best pharmaceuticals for children act

Human research subjects as human research workers

IRB Oversight of Patient-Centered Outcomes Research: A National Survey of IRB Chairpersons

Implementing Regulatory Broad Consent Under the Revised Common Rule: Clarifying Key Points and the Need for Evidence

Incorporating ethical principles into clinical research protocols: a tool for protocol writers and ethics committees

Informed Consent and the Role of the Treating Physician

Informed Consent and the Role of the Treating Physician

Institutional Review Board Quality, Private Equity, and Promoting Ethical Human Subjects Research

Institutions as an ethical locus of research prioritisation

Making the case for completion bonuses in clinical trials

Minimal or reasonable? Considering the ethical threshold for research risks to nonconsenting bystanders and implications for nonconsenting participants

Mountains and Molehills When Using Social Media as a Research Support Tool

No Easy Answers in Allocating Unapproved COVID-19 Drugs Outside Clinical Trials

Nonexceptionalism, Research Risks, and Social Media: Response to Open Peer Commentaries on "Using Social Media as a Research Recruitment Tool: Ethical Issues and Recommendations".

Of Parachutes and Participant Protection: Moving Beyond Quality to Advance Effective Research Ethics Oversight

Offering Payment in Clinical Research: Enrolling Individuals With or at Risk for Opioid Use Disorder

On Scarcity and the Value of Clinical Trials.

Oversight of Patient-Centered Outcomes Research: Recommendations From a Delphi Panel

Participant Protection in Phase 1 Pediatric Cancer Trials

Patient-Centered Outcomes Research: Stakeholder Perspectives and Ethical and Regulatory Oversight Issues

Patient-Engaged Research: Choosing the "Right" Patients to Avoid Pitfalls

Pay-to-Participate Trials and Vulnerabilities in Research Ethics Oversight

Paying Clinical Trial Participants: Legal Risks and Mitigation Strategies

Paying Participants in COVID-19 Trials

Paying Research Participants: Regulatory Uncertainty, Conceptual Confusion, and a Path Forward

Paying Research Participants: The Outsized Influence of "Undue Influence".

Prescription Requirements and Patient Autonomy: Considering an Over-the-Counter Default

Promoting Patient Interests in Implementing the Federal Right to Try Act

Protecting clinical trial participants and study integrity in the age of social media

Public Engagement, Notice-and-Comment Rulemaking, and the Common Rule

Reaping the Bounty of Publicly Available Clinical Trial Consent Forms

Regulating Research with Biospecimens under the Revised Common Rule

Regulatory flexibility for COVID-19 research

Revised 'Common Rule' Shapes Protections For Research Participants.

Right to Try Requests and Oncologists' Gatekeeping Obligations

Streamlining review by accepting equivalence

The Journey Toward Routinization: Triage Nursing and the Success of an Emergency Department-Based Routine HIV Testing Program

The Legality of Biometric Screening of Professional Athletes

The right to withdraw from controlled human infection studies: Justifications and avoidance

The rights and wrongs of intentional exposure research: contextualising the Guatemala STD inoculation study

The role of community engagement in addressing bystander risks in research: The case of a Zika virus controlled human infection study

Truth in Advertising: Disclosure of Participant Payment in Research Recruitment Materials

Unnecessary hesitancy on human vaccine tests-Response

Using Social Media as a Research Recruitment Tool: Ethical Issues and Recommendations

Waivers and Alterations of Research Informed Consent During the COVID-19 Pandemic

When clinical trials compete: prioritising study recruitment

When religious freedom clashes with access to care